Hennion & Walsh Asset Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.37M | Sell |
93,771
-1,400
| -1% | -$50.4K | 0.14% | 191 |
|
|
2025
Q1 | $3.75M | Sell |
95,171
-2,462
| -3% | -$97.1K | 0.17% | 155 |
|
|
2024
Q4 | $2.94M | Sell |
97,633
-996
| -1% | -$30K | 0.13% | 194 |
|
|
2024
Q3 | $2.31M | Sell |
98,629
-2,740
| -3% | -$64.1K | 0.11% | 244 |
|
|
2024
Q2 | $1.8M | Sell |
101,369
-83,446
| -45% | -$1.48M | 0.09% | 273 |
|
|
2024
Q1 | $2.81M | Buy |
184,815
+26,761
| +17% | +$407K | 0.15% | 187 |
|
|
2023
Q4 | $2.7M | Buy |
158,054
+31,868
| +25% | +$544K | 0.15% | 192 |
|
|
2023
Q3 | $1.05M | Sell |
126,186
-3,570
| -3% | -$29.8K | 0.07% | 347 |
|
|
2023
Q2 | $3.22M | Sell |
129,756
-1,872
| -1% | -$46.5K | 0.19% | 133 |
|
|
2023
Q1 | $1.98M | Sell |
131,628
-3,814
| -3% | -$57.4K | 0.12% | 209 |
|
|
2022
Q4 | $1.6M | Sell |
135,442
-68,140
| -33% | -$806K | 0.1% | 242 |
|
|
2022
Q3 | $1.21M | Buy |
203,582
+13,913
| +7% | +$82.4K | 0.08% | 287 |
|
|
2022
Q2 | $806K | Buy |
189,669
+60,149
| +46% | +$256K | 0.05% | 369 |
|
|
2022
Q1 | $1.23M | Buy |
129,520
+11,585
| +10% | +$110K | 0.07% | 296 |
|
|
2021
Q4 | $2.24M | Buy |
117,935
+14,121
| +14% | +$268K | 0.11% | 217 |
|
|
2021
Q3 | $3.46M | Sell |
103,814
-2,289
| -2% | -$76.2K | 0.18% | 164 |
|
|
2021
Q2 | $4.12M | Buy |
106,103
+14,648
| +16% | +$568K | 0.22% | 117 |
|
|
2021
Q1 | $4.41M | Buy |
+91,455
| New | +$4.41M | 0.26% | 97 |
|